The Forefront of Radiopharmaceuticals: History of α-Emitters with a Focus on Radiobiology, Physics and Clinical Considerations, Upcoming Webinar Hosted by Xtalks
TORONTO, Sept. 5, 2023 /PRNewswire-PRWeb/ -- CRO and Biotech Discuss Advancements in Radiotherapy
- There are recent reports showing impressive safety and tumor response with α-particle therapy across many solid tumor populations.
- In an upcoming webinar, Medpace Radiation Oncologist, Radiation Clinical Pharmacologist, are joined by a biotech Molecular Imaging Director, and Academic Medical Physicist to cover considerations in α-particle therapy.
- There are recent reports showing impressive safety and tumor response with α-particle therapy across many solid tumor populations.
- Click here to learn more about Medpace' s radiation therapy, radiopharmaceutical and radiation oncology solutions.